Re: AHA 2018
in response to
by
posted on
Nov 11, 2018 10:41AM
Bear
Totally agree ; Jelis data cleaner and Reduce absolutely confirms EPA as effective . The degree of difference is the only issue and FDA will allow what they allow for claims. I would call your attention to CXA-10 in P2 for PAH. I very strongly believe that nitrated Pufas will very shortly leapfrog all of the current class of omega 3’s , 6’s etc. etc.. that are the current rage. Nitrated Pufas share a number of pathways with RVX 208, such as Nfkb and Nrf2 as I have previously pointed to. Will Amarin buy Acasti out ? Will Astra buy both ? I think the entire space is too immature and the risk of being made obsolete too great . Just all my 2 Cents.
Thank you for all your great contributions !
Top